期刊文献+

HGF/c-Met、VEGF和uPA在口腔鳞癌组织中的表达及意义 被引量:14

Expression of HGF/c-Met,VEGF and uPA in oral squamous cell carcinoma
原文传递
导出
摘要 目的:探讨口腔鳞癌中HGF/c-Met、VEGF和uPA的表达及其相关性。方法:应用免疫组织化学SP法检测63例口腔癌、20例正常口腔黏膜的HGF/c-Met、VEGF和uPA蛋白表达。结果:①HGF/c-Met、VEGF和uPA阳性表达率:口腔鳞癌中分别为98.41%、100%、92.06%、88.89%,均显著高于正常口腔黏膜中表达率(5.00%、10.00%、20.00%、15.00%),P<0.05;有淋巴结转移的口腔癌组强阳性表达率分别为72.73%、77.27%、72.73%、68.82%,高于无转移组(53.66%、46.34%、46.34%、43.90%)。T3、T4期HGF/c-Met、VEGF和uPA的强阳性表达(93.10%、82.76%、72.41%、79.31%)高于T1、T2期(32.35%、35.29%、41.18%、29.41%),P<0.05。②口腔鳞癌中HGF/c-Met、VEGF和uPA表达呈正相关。结论:HGF/c-Met、VEGF和uPA表达与口腔癌的发生、发展相关,对口腔鳞癌的浸润、转移起促进作用且相互协同,是口腔鳞癌侵袭的重要标志物。 Objective:To evaluate the expression and the correlations of HGF/c-Met,VEGF,and uPA in oral squamous cell carcinoma. Method:Immunohistochemical SP method was used to detect the expression of HGF/c-Met,VEGF and uPA in series of 63 OSCCs and 20 normal oral epithelial tissues. Result:The positive rate of HGF/c-Met,VEGF,and uPA in OSCC was 98.41 %,100 %,92.06 % and 88.89 % respectively,which was significantly higher than that of the normal group (5.00 %,10.00 %,20.00 % and 15.00 %)P 0.05. There was significant difference between the tissues with (72.73 %,77.27 %,72.73 % and 68.82 %)and without node involvement(53.66 %,46.34 %,46.34 % and 43.90 %);and the expression of HGF/c-Met,VEGF,and uPA in stage T3-T4 93.10 %,82.76 %,72.41 % and 79.31 %)was significant higher than that in stage T1-T2(32.35 %,35.29 %,41.18 % and 29.41 %),P 0.05. There was a positive relation between HGF/c-Met,VEGF,and uPA expression. Conclusion:The expression of HGF/c-Met,VEGF,and uPA are related to the invasion of OSCC. HGF/c-Met,VEGF,and uPA could serve as an important index to estimate the biological behavior and prognosis of OSCC.
出处 《临床口腔医学杂志》 2010年第1期8-11,共4页 Journal of Clinical Stomatology
  • 相关文献

参考文献9

  • 1Tamura M,Daikuhara Y.Structure and function of hepatocyte growth factor/scatter factor(HGF/SF)[J].Curr Topics Biochem Res,2000,2:149-159.
  • 2刘崇梅.HGF/C-Met系统与头颈鳞癌相关性研究的进展[J].国外医学(耳鼻咽喉科学分册),2003,27(5):276-279. 被引量:5
  • 3Morimoto A,Tada K,Nakayama Y,et al.Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells[J].Jpn.J Cancer Res,1994,85:53-62.
  • 4王靖雯,沈朝妍,王伟,程建新.尿激酶型纤溶酶原激活系统与卵巢恶性肿瘤[J].国外医学(妇幼保健分册),2005,16(6):431-434. 被引量:3
  • 5Yamamotoa Tj,Maruia T,Akisue T.Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma[J].Pathology Research and Practice,2004,200:397-402.
  • 6Yonemura Y,Kaji M,Hirono Y.Correlation between overexpression of c-met and the progression of gastric cancer[J].Int J Oncol,1996,8:555-560.
  • 7Wu CW,Chi CW,Su TL,et al.Serum hepatocyte growth factor level associate with gastric cancer progression[J].Anticancer Res,1998,18:3657-3659.
  • 8雷志敏,赵怡芳,尚政军.肿瘤血管形成方式及其分子机制[J].国际口腔医学杂志,2006,33(6):466-468. 被引量:7
  • 9Offersena BV,Pfeiffer P,Andreasenc P.Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer:Relation to prognosis and angiogenesis[J].Lung Cancer,2007,56:43-50.

二级参考文献61

  • 1[1]Auguste P,Lemiere S,Larrieu-Lahargue F,et al.Crit Rev Oncol Hematol,2005,54(1):53-61.
  • 2[2]Bergers G,Brekken R,McMahon G,et al.Nat Cell Biol,2000,2(10):737-744.
  • 3[3]Auguste P,Gursel DB,Lemiere S,et al.Cancer Res,2001,61 (4):1717-1726.
  • 4[4]Patan S,Munn LL,Tanda S,et al.Circ Res,2001,89(8):723-731.
  • 5[5]Djonov V,Baum O,Burri PH.Cell Tissue Res,2003,314(1):107-117.
  • 6[6]Crivellato E,Nico B,Vacca A,et al.Leukemia,2004,18(2):331-336.
  • 7[7]Rafii S.J Clin Invest,2000,105(1):17-19.
  • 8[8]Rabbany SY,Heissig B,Hattori K,et al.Trends Mol Med,2003,9(3):109-117.
  • 9[9]Lyden D,Hattori K,Dias S,et al.Nat Med,2001,7(11):1194-1201.
  • 10[10]Davidoff AM,Ng CY,Brown P,et al.Clin Cancer Res,2001,7(9):2870-2879.

共引文献12

同被引文献155

引证文献14

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部